Business Context and Reporting Period
This Form 8-K Current Report was filed by Organogenesis Holdings Inc. on April 15, 2022. The filing primarily addresses corporate governance matters, specifically the scheduling of the 2022 Annual Meeting of Stockholders and a recent expansion of the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate events and does not contain financial performance data.
Material Changes
- Board Expansion: On April 14, 2022, the Board of Directors increased its size from nine to eleven members.
- Independence Requirement: The expansion anticipates the appointment of two additional independent directors by May 6, 2022, to comply with Nasdaq listing rules requiring a majority of independent directors following the company's exit from "controlled company" status.
- Annual Meeting Date: The 2022 Annual Meeting is scheduled for June 23, 2022.
- Record Date: Shareholders of record as of the close of business on April 25, 2022, are entitled to vote.
Guidance, Outlook, and Governance Procedures
Management Commentary and Outlook: The Company expects the two new independent directors to be nominated for re-election at the 2022 Annual Meeting. The specific time and location of the meeting will be detailed in the definitive proxy statement.
Shareholder Nomination Deadlines: Due to the public announcement of the board size increase in this filing, the deadline for stockholders to deliver notice of director nominations or business proposals for the 2022 Annual Meeting is the close of business on April 25, 2022. This date is 10 days following the filing of this Current Report.
Rule 14a-8 Proposals: The deadline for submitting proposals for inclusion in the Company's proxy materials under Rule 14a-8 is also April 25, 2022.
Investor Verification Checklist
- Verify the definitive proxy statement for the exact time and location of the June 23, 2022, Annual Meeting.
- Confirm the identities of the two new independent directors once appointed by May 6, 2022.
- Review the Company's Bylaws regarding the specific notice requirements for shareholder proposals if the meeting date is adjourned or postponed.
- Note that this filing contains no financial data; refer to the most recent 10-K or 10-Q for financial metrics.